295 / 1068
Other Prognostic Factors
•
ACT 1 trial :
low Hb associated with increased anal cancer
death ( p=0.008 )
•
EORTC 22861 :
skin ulceration associated with loco-regional
failure (p=0.003) and overall survival(p=0.005)
|
|
295 / 1068
Other Prognostic Factors
•
ACT 1 trial :
low Hb associated with increased anal cancer
death ( p=0.008 )
•
EORTC 22861 :
skin ulceration associated with loco-regional
failure (p=0.003) and overall survival(p=0.005)